Vaccine composition | Trade name | Manufacturer | Approved use in ACIP routine schedule* | Comments |
IPV | Ipol (PoliovaxΔ) | Sanofi Pasteur | 2, 4, 6 to 18 months, and 4 to 6 years¶ | Approved for use in infants, children, and adults◊ |
DTaP-HepB-IPV§ | Pediarix | GlaxoSmithKline | 2, 4, and 6 months | Approved for first 3 doses of IPV through age 6 years¥ |
DTaP-IPV/Hib‡ | Pentacel | Sanofi Pasteur | 2, 4, 6, and 15 to 18 months† | Approved for 4 doses of IPV through age 4 years** |
DTaP-IPV¶¶ | Kinrix | GlaxoSmithKline | 4 to 6 years | Approved for booster dose at age 4 to 6 yearsΔΔ |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟